As an oncogene, PRMT5 serves critical functions in several cellular responses, including the development, progression, and aggressiveness of cancer, and has been studied in multiple tumour types, including leukaemia, lymphoma, lung cancer, liver cancer, colorectal cancer and breast cancer39–43. This evidence concerns the gene PRMT5 and leukemia.